Kirsteen Mackay
Forget Airbnb income! Why I think a stock portfolio is an easier route to passive income
Airbnb hosting my seem like an easy second income, but I think a stock portfolio is an easier route to generating additional funds More »
A FTSE 250 and FTSE 100 insurance stock comparison
Lancashire Holdings Limited (LON:LRE) and FTSE 100 (INDEXFTSE: UKX) stock Hiscox Ltd (LON:HSX) are displaying positive signs of resilience More »
Is this FTSE 250 stock making a comeback or dead in the water?
I think defence and aerospace heavyweight Cobham plc (LON:COB) is emerging stronger after a disastrous few years, but would I buy? More »
Is this Kier competitor stock a bargain?
Kier Group plc (LON:KIE) rival Mitie has gone through some turbulent times, but I think its future looks more promising than that of its... More »
This FTSE 100 stock has grown for 8 years – would I buy now?
I think the size and reputation of Rentokil Initial plc (LON:RTO) mean this FTSE 100 (INDEXFTSE: UKX) stock can continue to gain market share,... More »
Forget buy-to-let: I prefer this FTSE 250 Stock to give me a slice of the property market
I think Primary Health Properties Plc (LON:PHP) is a FTSE 250 stock with a solid business model and impressive gains. More »
Forget Kier Group, I’d buy these 2 FTSE 100 shares instead
With the fallout from the demise of Kier Group plc (LON: KIE) still causing the share price to drop, I've been looking to alternative... More »
£5,000 to invest? I’d buy this dividend growth stock today
Cohort plc (LON:CHRT), with its soaring share price, is making all the right decisions. More »
Forget Ted Baker! I’d buy this FTSE 250 stock instead
With Ted Baker plc (LON: TED) under strain, continued doom and gloom on the high street and share prices falling, are any retailers worth... More »
Dare you buy oil stocks as shipping lanes are threatened?
Political unrest, the threat of oil sanctions and shipping lane blocks are bumping oil share prices. Royal Dutch Shell Plc Class B (LON: RDSB)... More »
Why I think AstraZeneca is a must-buy dividend stock
A steadily climbing share price, varied product development and positive trial results point to continued success for this big pharma leader AstraZeneca plc (LON:AZN). More »
